Nerea Lopetegui-Lia, MD (@nerealiamd) 's Twitter Profile
Nerea Lopetegui-Lia, MD

@nerealiamd

🇪🇸🇪🇺🇺🇸 Heme/Onc Fellow @ClevelandClinic | Former Resident and Chief Res at @UConnIM | @unicomplutense Alum | Interested in Breast Cancer #bcsm #immunoOnc

ID: 1142660617054150656

calendar_today23-06-2019 05:08:15

577 Tweet

758 Takipçi

1,1K Takip Edilen

Roberto Borea, MD (@robertoboreamd) 's Twitter Profile Photo

Our review on key advancements in #liquidbiopsy in 2024 is finally out! This work was made possible thanks to the incredible team effort of the International Society of Liquid Biopsy Young Committee. 📰Check it out! ➡️ sciencedirect.com/science/articl…

Our review on key advancements in #liquidbiopsy in 2024 is finally out!

This work was made possible thanks to the incredible team effort of the <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>  Young Committee.

📰Check it out! ➡️ sciencedirect.com/science/articl…
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

👏Congratulations to Dana-Farber's Filipa Lynce, MD, FASCO (Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸), recipient of the Advanced Clinical Research Award in #BreastCancer Research from Conquer Cancer, the ASCO Foundation. Dr. Lynce's work will focus on deciphering mechanisms of response to novel therapies in HER2 expressing

👏Congratulations to <a href="/DanaFarber/">Dana-Farber</a>'s Filipa Lynce, MD, FASCO (<a href="/FilipaLynce/">Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸</a>), recipient of the Advanced Clinical Research Award in #BreastCancer Research from <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a>. 
Dr. Lynce's work will focus on deciphering mechanisms of response to novel therapies in HER2 expressing
Nancy Lin, MD (@nlinmd) 's Twitter Profile Photo

What happens when you query chatGPT with 362 breast cancer cases? -46% responses differed from breast cancer expert opinion -when the same case was entered 3 times, the responses differed ~2/3 of the time ! -for examples, see 🧵..

Nerea Lopetegui-Lia, MD (@nerealiamd) 's Twitter Profile Photo

I could not have summarized it better Nicholas Hornstein Preparing for boards and navigating fellow-to-attending transition is intense — but staying connected makes it lighter! Lean on family, friends, mentors, colleagues (old and new). It makes all the difference! Hem-Onc Fellows Network

Arya Roy (@royaryam) 's Twitter Profile Photo

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

🚨Proud to share our publication in <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> 
🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/NazliDizman/">Nazli Dizman</a> <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a> <a href="/IMG_Oncologists/">IMG Oncologists</a> <a href="/GlopesMd/">gilberto lopes</a>
Nerea Lopetegui-Lia, MD (@nerealiamd) 's Twitter Profile Photo

🚴‍♀️On 8/2, I’ll be cycling 50 miles with Pelotonia to raise funds for cancer research. 💯% of donations go directly to research #EndingCancer #OneGoal Please consider supporting my ride pelotonia.org/profile/NL9672…

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Wonderful editorial by Marko Velimirovic MD MMSc & Jame Abraham, MD, FACP accompanying our JCO Oncology Practice review on the evolution of HER2 testing in oncology. Recommend reading to anyone interested in a recap of the epic journey of HER2 as a biomarker over the past 30 years. ascopubs.org/doi/10.1200/OP…

Wonderful editorial by <a href="/marko_velimir/">Marko Velimirovic MD MMSc</a> &amp; <a href="/jamecancerdoc/">Jame Abraham, MD, FACP</a> accompanying our <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> review on the evolution of HER2 testing in oncology. Recommend reading to anyone interested in a recap of the epic journey of HER2 as a biomarker over the past 30 years. ascopubs.org/doi/10.1200/OP…
Noha N. Soror, MD, MSc. 𓂀 (@noha_soror) 's Twitter Profile Photo

Happy July to all new fellows! 🎉 Fionnuala Crowley and I are excited to share our new article: Balancing the Scales: Real-Life Fellows’ Perspectives on Navigating Work-Life Balance in Oncology Training and Beyond | ASCO Connection connection.asco.org/do/balancing-s… We truly enjoyed writing

Elisabeth Potter MD (@epottermd) 's Twitter Profile Photo

I’m sharing an actual recent peer-to-peer call that shows what physicians and patients face when trying to get a surgery approved. This call felt as absurd as it sounds. The peer-to-peer call was to advocate for surgery to prevent and treat lymphedema for a patient with breast

Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Don't miss Dr. Ana Garrido-Castro at the Memorial Cancer Institute’s Best of #ASCO25 symposium on Aug 1st where she will discuss #TNBC and #Immunotherapy. And on Aug 2nd at the Show Me the Data® satellite symposium on New and Emerging Roles for #OralSERD Therapy in the Treatment

Don't miss Dr. Ana Garrido-Castro at the Memorial Cancer Institute’s Best of #ASCO25 symposium on Aug 1st where she will discuss #TNBC and #Immunotherapy. And on Aug 2nd at the Show Me the Data® satellite symposium on New and Emerging Roles for #OralSERD Therapy in the Treatment
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Follow-up results from the POSITIVE Trial regarding breastfeeding after hormone receptor-positive #BreastCancer show no differences in breast cancer related events in women who breastfed compared with those who did not. 👉pubmed.ncbi.nlm.nih.gov/40632989/ Fedro Peccatori MD, PhD Ann Partridge MD, MPH

Follow-up results from the POSITIVE Trial regarding breastfeeding after hormone receptor-positive #BreastCancer show no differences in breast cancer related events in women who breastfed compared with those who did not. 
👉pubmed.ncbi.nlm.nih.gov/40632989/
<a href="/fedrophd/">Fedro Peccatori MD, PhD</a> <a href="/AnnPartridgeMD/">Ann Partridge MD, MPH</a>
Nerea Lopetegui-Lia, MD (@nerealiamd) 's Twitter Profile Photo

Incredible work by Dr. Wesolowski from The James et al looking at gedatolisib+palbo+letrozole triplet in treatment-naïve advanced HR+/HER2- breast cancer